Botulinum Toxin Market, By Product (Type A & Type B), By Application (Therapeutics & Cosmetic) and Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
|
Report ID
AV164
|
Published Date
March 2020
|
Pages
106
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The botulinum toxin market is estimated to represent a global market of USD 3.93 billion by 2017 with growth rate of 8.2%.
Botulinum toxin (also termed as miracle poison) is a type of poisonous biological substance, neurotoxic protein, produced by bacterium Clostridium botulinum species. This species is a gram-positive, spore-forming, anaerobic rod commonly found in soil, plants & in water. Botulinum toxin acts by interfering with neural transmission and blocks the release of acetylcholine which may cause muscle paralysis. This drug is injected into a patient using a 30-gauge 1-inch needle to the affected muscles.
Market Dynamics
Growing demand for minimally invasive treatment coupled with increasing therapeutic use of this toxin is further driving the market growth. For example, nowadays, botulinum toxins play a very important role in the management of medical conditions such as focal dystonias, hyperhidrosis, hypersalivation, headaches, and hemifacial spasm. Additionally, the list of possible use of this protein as therapeutic in various disease condition is rapidly expanding which will provide significant growth opportunities for this market to grow. However, high side effects and lack of reimbursement coverage for this treatment hampers the market growth to some extent. For example, most procedures are intended for an aesthetic purpose such as to reduce fat and wrinkles which are not covered by reimbursement policies.
Product Takeaway
The product segment is divided as Type A, and Type B. Type A segment is considered to generate a major chunk of the global industry, more than 96% of the revenue share is captured by this segment throughout the forecast period. Growing demand coupled with increasing government approvals of Type A botulinum toxins drive the segment growth. Type A segment is further categorized as Dysport, Xeomin, Botox, and other. Whereas, Myobloc is an example of type B preparation. In terms of end users, the market is categorized as Therapeutic, and Cosmetic applications. Among which, the cosmetic application is accounted for the highest share of the global market. In 2017, this segment achieved USD 2.62 billion and is projected to grow by 8.3% over the study period.
Regional Takeaway
Regionally, North America accounted for the 36.23% share of the global market in 2017. Growing demand for this treatment for aesthetic appearance coupled with increasing disposable income drives the regional growth. Whereas, Europe is projected to capture more than 26% share of the overall industry by 2025. Availability of effective botulinum treatments augments the growth in this region. For example, Dysport, the type A product available in Europe and is widely distributed in 500-unit vials which can be stored at room temperature. Trailed closely by the Asia Pacific, this region is expected to grow with a significant growth rate over the study period. Growing medical tourism industry coupled with increasing geriatric population is anticipated to support the growth. For example, according to the World Bank, more than 25.0% of the Japanese population is over 65 years of age.
Key Vendor Takeaway
Companies namely Allergan, Ipsen Group, Medytox, and Metabiologics are some of the key companies operating in this market. Growing research and activities in collaboration with government organizations helped these companies to attain the notable market position. For instance, in May 2016, Ipsen signed a partnership agreement with the Institute of Molecular and Cell Biology (IMCB) for the study of intracellular trafficking of the Botulinum neurotoxins in the neurons. The partnership is expected to help both the companies expand applications of botulinum toxins.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Hospitals
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY PRODUCT
- Type A
- Dysport
- Xeomin
- Botox
- Other
- Type B
- Myobloc
- Others
MARKET, BY APPLICATION
- Therapeutic
- Cosmetic
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. BOTULINUM TOXIN MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. BOTULINUM TOXIN KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. BOTULINUM TOXIN INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. BOTULINUM TOXIN MARKET LANDSCAPE
5.1. Market Share Analysis
6. BOTULINUM TOXIN MARKET – BY PRODUCT TYPE
6.1. Overview
6.2. Type A
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.3. Dysport
6.2.3.1. Overview
6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.4. Xeomin
6.2.4.1. Overview
6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.5. Botox
6.2.5.1. Overview
6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.2.6. Other
6.2.6.1. Overview
6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. Type B
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3.3. Myobloc
6.3.3.1. Overview
6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3.4. Others
6.3.4.1. Overview
6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. BOTULINUM TOXIN MARKET – BY APPLICATION
7.1. Overview
7.2. Therapeutic
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Cosmetic
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. BOTULINUM TOXIN MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9. KEY VENDOR ANALYSIS
9.1. Allergan
9.1.1. Company Overview
9.1.2. SWOT Analysis
9.1.3. Key Developments
9.2. Ipsen Group
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. Medytox
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. Metabiologics
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
*Client can request additional company profiling as per specific requirements
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Botulinum Toxin Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Botulinum Toxin Market, by Product, 2014 – 2025 (USD Billion)
Table 11 Botulinum Toxin Market, by Application, 2014 – 2025 (USD Billion)
Table 12 Botulinum Toxin Market, by Geography, 2014 – 2025 (USD Billion)
Table 13 North America Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 14 U.S. Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 15 Canada Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 16 Europe Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 17 France Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 18 Germany Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 19 Asia Pacific Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 20 China Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 21 India Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 22 Latin America Botulinum Toxin Market, 2014 – 2025 (USD Billion)
Table 23 MEA Botulinum Toxin Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Botulinum Toxin Market, by Product, 2014 – 2025 (USD Billion)
Figure 7 Botulinum Toxin Market, by Application, 2014 – 2025 (USD Billion)
Figure 8 Botulinum Toxin Market, by Geography, 2014 – 2025 (USD Billion)
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
